OTO-201 for the Treatment of Otitis Externa

Status Completed

Clinical Trial Summary

This is a 1-month, multicenter, open-label study in subjects with unilateral otitis externa. Eligible subjects will receive a single dose of 6 mg OTO-201 to the affected ear. The study is designed to characterize safety, procedural factors and clinical effect of OTO-201 administered in subjects with otitis externa.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02511561
Study type	Interventional
Source	Otonomy, Inc.
Contact
Status	Completed
Phase	Phase 2
Start date	July 2015
Completion date	November 2015

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT00523120` - Topical Voltaren in Otitis Externa	Phase 2
Completed	`NCT00872209` - Safety and Efficacy Study of Foam Otic Cipro Compared to a Standard Solution ( Ciloxan - Alcon Labs ) to Treat Acute Otitis Externa	Phase 1/Phase 2
Recruiting	`NCT05370209` - Performance and Safety of Otinova® Ear Spray	N/A
Completed	`NCT02558738` - Non Interventional Clinical Investigation of Ectoin Ear Spray in Skin Treatment of Outer Ear Canal Irritations	N/A
Terminated	`NCT01910155` - A Bioequivalence Study of Two Ciprofloxacin/Dexamethasone Formulations in Patients With Otitis Externa	Phase 3
Completed	`NCT01359098` - Efficacy and Safety of Once-Daily Ciprodexa Otic Foam Compared to Twice-daily Ciprodex Ear Drops in Acute Otitis Externa	Phase 2
Completed	`NCT01157819` - Safety and Efficacy of Once-Daily Dosing of FoamOtic Cipro Compared to Twice-Daily Dosing of Ciloxan Ear Drops in Patients With Acute External Otitis	Phase 2
Completed	`NCT00980876` - A Comparative Study Between Two Formulations of the Ciprofloxacin Hydrochloride + Hydrocortisone Otic Suspension	Phase 3